Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hafnium is a venture capital organization founded in 2017 and headquartered in Singapore. The firm operates at the intersection of technology and innovation, focusing on food technology, natural materials, and specialty chemicals. Hafnium employs a venture builder model, which allows it to identify and commercialize innovative technologies while also making traditional capital investments.
As of now, Hafnium has established a presence across Europe, the United States, Japan, and China, enhancing its ability to tap into diverse markets. The firm also has a private equity investment arm, Hafnium Capital, which concentrates on small and medium-sized transactions. This dual approach enables Hafnium to support its portfolio companies effectively, providing both capital and operational expertise.
Notable milestones include exclusive licensing agreements with A*STAR, a government research agency in Singapore, which have facilitated the commercialization of innovative products. Hafnium's commitment to early-stage technologies positions it as a significant player in the sectors it targets.
Hafnium is dedicated to supporting very early-stage technologies, particularly in food tech and biotech. The firm focuses on commercialization through partnerships with government research agencies, especially A*STAR, to bring innovative products to market. This collaboration allows Hafnium to leverage institutional knowledge and resources, enhancing the potential for successful product launches.
The investment strategy encompasses a range of sectors, including food-agtech, biotech, and healthcare. Hafnium typically invests at the pre-seed and seed stages, targeting small and medium-sized transactions. The firm seeks to identify startups that demonstrate strong potential for innovation and market impact, particularly those that align with its focus on specialty chemicals and natural materials.
Hafnium values founders who possess a deep understanding of their respective industries and who are committed to driving technological advancements. The firm’s deal structure often involves co-investment opportunities, particularly with government entities, to facilitate access to additional resources and commercialization pathways.
Hafnium's portfolio includes two notable companies:
Both companies exemplify Hafnium's commitment to supporting early-stage technologies in the food and biotech sectors. The firm's strategic partnerships with A*STAR have been instrumental in the development and commercialization of these startups, showcasing its ability to bridge the gap between research and market readiness.
Recent activity from Hafnium includes an exclusive license agreement with A*STAR to commercialize low-calorie noodles through the spinoff NOBA. This agreement highlights Hafnium's commitment to bringing innovative food technologies to market.
Additionally, Hafnium has established a joint venture with A*STAR to launch Fermatics, a biotech startup focused on developing advanced biotechnological solutions. These initiatives underscore Hafnium's active role in fostering early-stage technologies in its target sectors.
What are Hafnium's investment criteria?
Hafnium focuses on very early-stage technologies in food tech, biotech, and healthcare. The firm seeks startups that demonstrate innovative solutions and have the potential for significant market impact.
How can founders pitch Hafnium?
Founders interested in pitching Hafnium should prepare a detailed presentation that outlines their technology, market potential, and team expertise. A warm introduction is preferred, but cold outreach is also accepted.
What makes Hafnium different from other VC firms?
Hafnium distinguishes itself through its venture builder model and strong partnerships with government research agencies like A*STAR. This approach provides portfolio companies with unique access to resources and commercialization pathways.
What is Hafnium's geographic focus?
Hafnium operates globally, with a strong presence in Singapore, Europe, the United States, Japan, and China. This international reach allows the firm to tap into diverse markets and opportunities.
What is the typical check size for Hafnium's investments?
While specific check sizes are not disclosed, Hafnium primarily targets small and medium-sized transactions, particularly at the pre-seed and seed stages.
What kind of support do portfolio companies receive?
Hafnium provides operational support, access to its network, and guidance on commercialization strategies. The firm’s deep sector expertise in biotech and food technology enhances the value it adds to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.